0LER fundamentals
An in-depth look to TEVA PHARMACEUTICAL INDUSTRIES SPON ADR EACH REP 1 ORD SHS operating, investing, and financing activities
0LER free cash flow for Q1 24 is 47 M USD. For 2023, 0LER free cash flow was 2.32 B USD and operating cash flow was 2.85 B USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM